Ishizaka, Aya
Koga, Michiko
Mizutani, Taketoshi
Uraki, Ryuta
Yamayoshi, Seiya
Iwatsuki-Horimoto, Kiyoko
Yamamoto, Shinya
Imai, Masaki
Tsutsumi, Takeya
Suzuki, Yutaka
Kawaoka, Yoshihiro
Yotsuyanagi, Hiroshi
Funding for this research was provided by:
Japan Society for the Promotion of Science (22K20926, 21K07314, 21K11592)
The Yamaguchi Education and Scholarship Foundation
Moonshot Research and Development Program (JPMJMS2025)
Japan Agency for Medical Research and Development (UTOPIA, 223fa627001h0001, JP22wm0125002 and JP223fa627001)
Article History
Received: 23 March 2023
Accepted: 3 July 2023
First Online: 13 July 2023
Change Date: 19 July 2023
Change Type: Update
Change Details: We have removed the article category name from the title.
Declarations
:
: This study was approved by the Institutional Review Board of the Institute of Medical Science, University of Tokyo (IMSUT; approval number: (2020-74-0226). We confirmed that all methods were performed in accordance with the relevant guidelines and regulations. This study was conducted in accordance with the Declaration of Helsinki and written informed consent for sample collection and subsequent analysis was provided by all participants before enrolment.
: Authors declare that the results/data/figures in this manuscript have not been published elsewhere, nor are they under consideration by another publisher, and consent for publication upon acceptance by the journal.
: Y.K. has received unrelated funding support from Daiichi Sankyo Pharmaceutical, Toya-ma Chemical, Tauns Laboratories, Inc., Shionogi & Co. LTD, Otsuka Pharmaceutical, KM Biologics, Kyoritsu Seiyaku, Shinya Corporation, and Fuji Rebio.